SEC Filing Summary for Beta Bionics, Inc. - Officer/Director Transaction

This filing details a transaction by MICHEL GERARD J, a director at Beta Bionics, Inc. On May 21, 2026, 16,965 shares of Common Stock were acquired under an equity incentive plan, with a reported transaction price of $0.00. Following this transaction, the post-transaction shares owned by Mr. Gerard amount to 33,509. The transaction code is 'A', indicating an acquisition, and the ownership is direct.